Autoimmune Hemolytic Anemia (AIHA) is a rare, potentially life-threatening blood disorder. AIHA occurs when the body's own immune system mistakenly attacks and destroys healthy red blood cells. While AIHA can be a serious condition, it is usually treatable. In some cases, however, it can be fatal.
What is Autoimmune Hemolytic Anemia?
Autoimmune Hemolytic Anemia (AIHA) is a rare blood disorder which occurs when the body's own immune system mistakenly attacks and destroys healthy red blood cells. The destruction of these red blood cells, which are responsible for carrying oxygen to tissues throughout the body, results in anemia. AIHA can be caused by a variety of factors, including infections, drugs, and autoimmune diseases.
How is Autoimmune Hemolytic Anemia Diagnosed?
AIHA is typically diagnosed through a combination of physical examination, lab tests, and imaging tests. Common lab tests used to diagnose AIHA include a complete blood count, a blood smear, and a reticulocyte count. Imaging tests, such as an ultrasound or CT scan, may also be used to look for signs of an enlarged spleen or other complications.
Is Autoimmune Hemolytic Anemia Fatal?
In most cases, AIHA is treatable and not fatal. Treatment may include medications to suppress the immune system, transfusions of red blood cells, or even removal of the spleen. However, in some cases, AIHA can be fatal if left untreated. If you have been diagnosed with AIHA, it is important to work with your healthcare provider to develop an appropriate treatment plan.